| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.24 | 7e-09 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-07 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.29 | 4e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.24 | 4e-06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-05 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.26 | 7e-05 |